Furst Group Assists the American Society for Clinical Pathology with CEO Search
September 4, 2026 – Furst Group, which serves the healthcare and insurance industries, has assisted in the recruitment of Alexandra Brown as CEO of the American Society for Clinical Pathology (ASCP) following her successful tenure as interim CEO over the past year. The selection was made after a national search and based on the recommendation from a search committee appointed by ASCP’s executive committee. Dr. Brown’s exceptional clinical and executive leadership experience positioned her as the top choice for the ASCP board of directors, and with this appointment, she becomes the first woman to serve as the appointed CEO of ASCP.
“Having Dr. Brown as ASCP’s CEO bodes well for pathology and laboratory medicine,” said Greg Davis, president of ASCP. “Dr. Brown has the requisite medical expertise and experience that we must have, but she also brings qualities that we need. Her acute awareness and sensitivity to the needs of others is the foundation of her collaborative approach to improving practice standards and patient care.”
Since assuming the role of interim CEO in August 2025, Dr. Brown has demonstrated strong leadership, strategic vision, and a deep commitment to ASCP’s mission and evolution. “Throughout her tenure, she has emphasized engagement with pathologists, laboratory professionals, residents, and students, reinforcing her belief that the Society is strongest when its direction is shaped by those it serves,” the organization said.
An accomplished pathologist board certified in anatomic pathology, clinical pathology, and clinical informatics, Dr. Brown is a longtime and dedicated ASCP member and volunteer. She served in multiple leadership roles within the Society throughout her career, including two terms as a volunteer on the board of directors, 10 years on staff, most recently as chief medical officer. Her practical clinical experience coupled with a decade of work in the non-profit medical association industry provide a unique perspective on the opportunities and challenges facing the profession, from workforce pressures and evolving diagnostic technologies to the critical role pathology and laboratory medicine play in the broader healthcare ecosystem.
As CEO, Dr. Brown will build on that legacy while guiding and modernizing the Society to anticipate the needs of the rapidly evolving healthcare landscape. In partnership with the ASCP board of directors, which establishes the Society’s strategic priorities and long-term direction, Dr. Brown will continue to focus on advancing ASCP’s core mission. Priorities include enhancing member engagement, supporting workforce development, expanding ASCP’s influence and partnerships, investing in innovation, and modernizing programs to meet the evolving needs of pathologists and laboratory professionals.
Related: Furst Group Fills Top HR Post for Johns Hopkins Medicine
“I am honored to step into the role of CEO and continue serving an organization that is so vital to patients and the healthcare community,” said Dr. Brown. “ASCP’s strength has always been its members. My commitment is to lead with transparency, collaboration, and accountability while ensuring the Society remains responsive to the needs of pathologists and laboratory professionals. Together, we will build on ASCP’s strong foundation and advance our mission to improve patients’ lives through innovation, adaptation, and consistent excellence in pathology and laboratory medicine.”
Founded in 1922
The American Society for Clinical Pathology is a Chicago-based professional membership organization representing pathologists and laboratory professionals. Founded in 1922, the organization provides education, professional certification, advocacy, career resources, and other programs supporting the practice of pathology and laboratory medicine.
Furst Group, headquartered in Rockford, IL, partners with many of the premier healthcare organizations in the world, from providers and payers to life-science companies and private equity/venture capital firms. While Furst Group’s roots are in managed care, the firm continues to be one of the nation’s leading executive search partners to health systems, hospitals, academic medical centers, post-acute, and hospice and palliative care facilities. Its work with insurers stretches back to the HMO era, yet the firm also teams with life science, pharmaceutical, and medical device companies. Furst Group also has offices in Phoenix, AZ; Radnor, PA; San Francisco; Brentwood, TN; Chicago; Irving, TX; Minneapolis, MN; Seattle; St. Louis; and Washington, D.C.
Bob Clarke, chairman of Furst Group, has been a trusted advisor to CEOs and boards for more than 30 years. His acumen in executive search and integrated talent management is valued by hospital systems, managed care organizations, medical groups, indemnity companies, end-of-life care providers, healthcare associations, and other medical delivery systems across the U.S. Mr. Clarke concentrates his work at the board and C-suite levels for providers and payers of every variety, creating recruitment processes and counseling boards and search committees. He also partners with boards of directors of healthcare organizations to manage C-suite transitions, develop succession plans, assess leadership teams, and implement leadership development programs.
Related: Furst Group Recruits President and CEO of Blessing Health System
Contributed by Scott A. Scanlon, Editor-in-Chief and Dale M. Zupsansky, Executive Editor – Hunt Scanlon Media
